3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Menstruation Disturbances
1
Leiomyoma
1
Endometriosis
1
Endometrial Neoplasms
1
Adenomyosis
1
Interventions
Gemcitabine
2
Aminolevulinic Acid
2
toripalimab
1
tirbanibulin
1
ruxolitinib
1
potassium oxonate
1
penpulimab
1
human papillomavirus vaccine, L1 type 16, 18
1
gimeracil
1
apatinib
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Toremifene
1
Tegafur
1
Robotic Surgical Procedures
1
Rifampin
1
RAD140
1
Pregnancy Tests
1
Pemetrexed
1
ON 01910
1
Nivolumab
1
Itraconazole
1
Irinotecan
1
Injections
1
Infusions, Intravenous
1
Hysterectomy
1
Human Papillomavirus DNA Tests
1
High-Intensity Focused Ultrasound Ablation
1
Excipients
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Hysterectomy
×
Other neoplasm
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled